Salicylate fails to prevent the inhibitory effect of 5,8,11,14-eicosatetraynoic acid on human platelet cyclo-oxygenase and lipoxygenase activities
- 23 August 1983
- journal article
- research article
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - General Subjects
- Vol. 759 (1-2) , 125-127
- https://doi.org/10.1016/0304-4165(83)90197-6
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Non-steroidal anti-inflammatory drugs react with two sites on platelet cyclo-oxygenase evidence from ‘in vivo’ drug interaction studies in ratsBiochimica et Biophysica Acta (BBA) - General Subjects, 1982
- Sulphinpyrazone prevents in vivo the inhibitory effect of aspirin on rat platelet cyclo-oxygenase activityBiochemical Pharmacology, 1981
- Salicylate-aspirin interaction in the rat. Evidence that salicylate accumulating during aspirin administration may protect vascular prostacyclin from aspirin-induced inhibition.Journal of Clinical Investigation, 1981
- Inhibition of platelet lipoxygenase by toluene-3,4-dithiol and other ferric iron chelatorsProstaglandins and Medicine, 1981
- Selective inhibition of platelet n — 8 lipoxygenase by 5,8,11-eicosatriynoic acidBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1977
- On the formation of thromboxane B2 and 12L-hydroxy-5, 8,10,14-eicosatetraenoic acid (12 ho-20:4) in tissues from the guinea pigBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1976
- Arachidonate lipoxygenase in blood plateletsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1975